Ys Biopharma Co. Ltd WT (YSBPW)
Ys Biopharma Co. Ltd WT (YSBPW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YSBPW | ||||
| Company | Ys Biopharma Co. Ltd WT | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 0.0800 | ||||
| High | 0.0950 | ||||
| Low | 0.0800 | ||||
| Latest | 0.0950 | ||||
| Change | +0.0150 | ||||
| % Change | +18.75% | ||||
| Volume | 29,000 | ||||
| 20-Day Average Volume | 10,490 | ||||
| Previous Close | 0.0800 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.0842 | ||||
| 20-Day Raw Stochastic | 100.00% | ||||
| 20-Day Relative Strength | 56.17 | ||||
| Weighted Alpha | +44.08 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 88% Buy | ||||
| Last Month's Opinion | 88% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.73% since 05/16/24 | ||||
| Low | 0.0725 on 05/21/24 | ||||
| High | 0.0950 on 05/24/24 | ||||
| 1-Month | |||||
| %Chg | +7.34% since 04/24/24 | ||||
| Low | 0.0501 on 05/02/24 | ||||
| High | 0.0950 on 05/24/24 | ||||
| 3-Month | |||||
| %Chg | +35.91% since 02/23/24 | ||||
| Low | 0.0265 on 02/28/24 | ||||
| High | 0.1000 on 03/07/24 | ||||
| 6-Month | |||||
| %Chg | +350.24% since 11/24/23 | ||||
| Low | 0.0110 on 11/29/23 | ||||
| High | 0.1000 on 03/07/24 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 687,201,070 | ||||
| Annual Net Income | -145,479,105 | ||||
| Last Quarter Sales | 96,818,454 | ||||
| Last Quarter Net Income | -104,980,798 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||